NASDAQ · NPT

Texxon Holding Limited

$2.67 +$0.00 (+0.19%) 1D After hours

Key Metrics

$59.12M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$42.78M
Beta · 1Y -0.28
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 8
    The stock moved +283.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 8
  • May 14
    From its Mar 6 high, the share price fell 94%.

    Peak close $20.50 on Mar 6; trough close $1.21 on May 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -94%
  • Mar 3
    The stock moved +81.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$59.12M
Enterprise value$109.40M
Shares outstanding22.2M
52-wk range$1.14 – $22.38
Avg volume · 20D1.3M
Net cash −$50.28M
Book value / share$-0.17
ExchangeNASDAQ
About Texxon Holding Limited
IPO dateOct 22, 2025
Employees

Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio0.29
Quick ratio0.27
Debt / equity-13.85
Debt / EBITDA
Net cash −$50.28M
Working capital−$51.98M

Cash Flow · TTM

Operating CF $2.32M
Capex −$45.10M
Free cash flow −$42.78M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings